English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jan 7, 2026

FDA approves Vanda's Nereus as first new motion sickness drug in four decades
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

Researchers create first human lung-on-chip model using single-donor stem cells
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

KAIST develops therapy converting tumor-immune cells into direct anticancer agents
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

BioSpace announces NextGen Class of 2026 highlighting top biotech startups
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

FARE welcomes new dietary guidelines recommending early allergen introduction for infants
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

St. Jude scientists develop efficient method for assessing gene editing safety
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

Researchers find high bacterial loads hinder immunotherapy success in head and neck cancers
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

University of Toronto researchers identify biomarker linked to multiple sclerosis progression

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes